Patent Application
20240033434
The present application relates generally to devices and methods for delivering agents into a subject's body and, more particularly, to auto-injectors and/or gas-powered drive systems for injection devices, and to methods for making and using such devices.
There are many applications involving delivery of a medicament or other agent subcutaneously, intramuscularly, or otherwise into a patient's body. For example, auto-injectors are available that include a predetermined dose of the agent that may be delivered automatically into the patient's body, e.g., after placement against the patient's skin and activation. Generally, such auto-injectors are spring-loaded syringes that are activated to release the spring, which generates sufficient force to penetrate the skin with a needle and deliver the dose within the syringe. For viscous fluids, the forces required to develop fluid flow can be higher than spring-powered systems can provide. When springs can be used, they must generate a relatively high force that requires springs of high mass. Consequently, such auto-injectors may make substantial noise, create pressure spikes in the syringe leading to glass breakage, vibrate, and/or may drive the needle forcefully into the patient's skin, which may cause pain and/or may startle the user, particularly when the patient is administering the injection themselves.
Therefore, improved devices and methods for delivering agents into a patient's body would be useful.
The present application relates generally to devices and methods for delivering agents into a subject's body and, more particularly, to auto-injectors and/or gas-powered drive systems for injection devices, and to methods for making and using such devices.
In accordance with one example, an injector device is provided for delivering one or more agents into a subject's body that includes an outer housing comprising a proximal portion terminating in a proximal end and a distal portion terminating in an open distal end; a syringe comprising a barrel containing one or more agents, a needle extending distally from the barrel such that a tip of the needle is disposed within the distal portion adjacent the distal end, and a piston within a proximal end of the barrel; an inner housing within the outer housing comprising a first chamber adjacent the outer housing proximal end and a second chamber between the first chamber and the barrel proximal end; an activation cap on the distal end of the housing such that a contact surface is disposed distal to the outer housing distal end and an activation cap extension extends proximally around the barrel; a source of pressurized gas within the first chamber; a release cap within the outer housing adjacent the outer housing proximal end carrying an opener pin located adjacent the source of pressurized gas; a spacer adjacent the inner housing within the outer housing comprising a distal end adjacent a proximal end of the activation cap extension and a proximal end adjacent the release cap; and a plunger comprising a proximal end within the second chamber and a distal end coupled to the piston of the syringe. The activation cap is movable axially relative to the outer housing such that, when the contact surface of the activation cap is pressed against a subject's skin, the activation cap is configured to move proximally to direct the spacer proximally, the spacer consequently directing the release cap proximally to release the opener pin, thereby causing the opener pin to open the source of pressurized gas to release the pressurized gas into the first chamber and into the second chamber such that the pressurized gas advances the plunger to direct the piston distally to deliver the one or more agents through the needle. In addition, the spacer may be biased to advance distally such that, when the activation cap is released when the contact surface is directed away from the subject's skin after delivering the one or more agents, the spacer directs the activation cap distally to cover the needle, the spacer comprising one or more locking members for preventing subsequent proximal movement of the spacer and activation cap.
In accordance with another example, a device is provided for delivering one or more agents into a subject's body that includes an outer housing comprising a proximal portion terminating in a proximal end and a distal portion terminating in an open distal end; a syringe comprising a barrel containing one or more agents, a needle extending distally from the barrel such that a tip of the needle is disposed within the distal portion adjacent the distal end, and a piston within a proximal end of the barrel; an inner housing within the outer housing comprising a first chamber adjacent the outer housing proximal end and a second chamber between the first chamber and the barrel proximal end; an activation cap on the distal end of the housing such that a contact surface is disposed distal to the outer housing distal end; a source of pressurized gas within the first chamber; a release cap within the outer housing adjacent the outer housing proximal end carrying an opener pin located adjacent the source of pressurized gas, the release cap operatively coupled to the activation cap such that proximal movement of the activation cap directs the release cap proximally; and a plunger comprising a proximal end within the second chamber and a distal end coupled to the piston of the syringe. The activation cap may be movable axially relative to the outer housing such that, when the contact surface of the activation cap is pressed against a subject's skin, the activation cap is configured to retract proximally into the distal end to direct the release cap proximally to release the opener pin, thereby causing the opener pin to open the source of pressurized gas to release the pressurized gas into the first chamber and into the second chamber such that the pressurized gas advances the plunger to direct the piston distally to deliver the one or more agents through the needle.
In accordance with still another example, a method is provided for delivering one or more agents into a subject's body that includes providing an injector device comprising an outer housing carrying a syringe comprising a barrel containing one or more agents, and a needle extending distally from the barrel such that a tip of the needle is disposed adjacent an activation cap on a distal end of the outer housing; an inner housing within the outer housing comprising first and second chambers; and a source of pressurized gas within the proximal chamber; pressing a contact surface of the activation cap against the subject's skin to insert the needle into the skin, thereby retracting the activation cap proximally into the outer housing to cause a carriage carrying an opener pin to be released and advance to open an outlet of the source of pressurized gas into the first and second chambers, pressure from the pressurized gas advancing a plunger within the outer housing to deliver the one or more agents from the barrel through the needle into the subject's body; and withdrawing the needle from the subject's skin, the activation cap automatically advancing to cover the needle.
In accordance with yet another example, a method is provided for assembling an injector device that includes providing a forward housing comprising proximal and distal ends, and an activation cap on the distal end such that a contact surface is disposed distal to the distal end; providing a rear housing comprising proximal and distal ends and an interior extending therebetween, the rear housing including a release cap within the interior adjacent the rear housing proximal end carrying an opener pin located adjacent a source of pressurized gas, and an inner housing within the interior comprising first and second chambers, and a plunger comprising a proximal end within the second chamber; loading a syringe into an interior of the forward housing such that a needle of the syringe is located within the forward housing proximal to the contact surface; and coupling the rear housing distal end to the forward housing proximal end, thereby coupling the plunger to a piston within the syringe. The activation cap may be movable axially relative to the forward housing such that, when the contact surface of the activation cap is pressed against a subject's skin, the activation cap moves proximally to direct the release cap proximally to release the opener pin, thereby causing the opener pin to open the source of pressurized gas to release the pressurized gas into the first chamber and into the second chamber such that the pressurized gas advances the plunger to direct the piston distally to deliver the one or more agents through the needle.
Other aspects and features of the present invention will become apparent from consideration of the following description taken in conjunction with the accompanying drawings.
It is believed the present invention will be better understood from the following description of certain examples taken in conjunction with the accompanying drawings, in which like reference numerals identify the same elements and in which:
The drawings are not intended to be limiting in any way, and it is contemplated that various examples of the invention may be carried out in a variety of other ways, including those not necessarily depicted in the drawings. The accompanying drawings incorporated in and forming a part of the specification illustrate several aspects of the present invention, and together with the description serve to explain the principles of the invention; it being understood, however, that this invention is not limited to the precise arrangements shown.
Before the examples are described, it is to be understood that the invention is not limited to particular examples described, as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular examples only, and is not intended to be limiting, since the scope of the present invention will be limited only by the appended claims.
Where a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit unless the context clearly dictates otherwise, between the upper and lower limits of that range is also specifically disclosed. Each smaller range between any stated value or intervening value in a stated range and any other stated or intervening value in that stated range is encompassed within the invention. The upper and lower limits of these smaller ranges may independently be included or excluded in the range, and each range where either, neither or both limits are included in the smaller ranges is also encompassed within the invention, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the invention.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, some potential and exemplary methods and materials are now described.
It must be noted that as used herein and in the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to “a compound” includes a plurality of such compounds and reference to “the polymer” includes reference to one or more polymers and equivalents thereof known to those skilled in the art, and so forth.
Certain ranges are presented herein with numerical values being preceded by the term “about.” The term “about” is used herein to provide literal support for the exact number that it precedes, as well as a number that is near to or approximately the number that the term precedes. In determining whether a number is near to or approximately a specifically recited number, the near or approximating unrecited number may be a number which, in the context in which it is presented, provides the substantial equivalent of the specifically recited number.
Turning to the drawings,
In one example, the syringe 70 may be a pre-filled syringe, e.g., formed from glass, plastic, and the like, filled with a predetermined volume of agent, e.g., corresponding to a single dose for a patient. Alternatively, the agent chamber and needle may be integrated into the forward housing 10 if desired (not shown). In a further alternative, the syringe 70 (or integral agent chamber) may include a distal port (not shown) without a needle, such that a separate needle (also not shown) may be coupled to the port, e.g., using a Luer fitting, mating threads, and/or other cooperating connectors, immediately before an injection or otherwise as desired. As used herein, “agent” may include one or more flowable therapeutic and/or diagnostic compounds, medicaments, or materials, e.g., in liquid or gaseous form, in solution or suspension, and the like, such as viscous fluids.
With additional reference to
Generally, the device 6 is configured such that, when a contact surface 84 of the activation cap 80 is pressed against a subject's skin to insert the needle 78, the activation cap 80 retracts proximally into the outer housing 8 and automatically activates the opener mechanism 60 to release the pressurized gas from the canister 40 into the first and second chambers 22, 24, which generates a distal force to advance the plunger 50 to deliver the agent(s) from the syringe into the subject. After the injection is completed and the device 6 is withdrawn away from the skin, the activation cap 80 may automatically advance to cover the needle 78.
For example, a spacer 30 may be provided that extends between the activation cap and a release cap 34 adjacent the opener mechanism 60, e.g., such that proximal movement of the activation cap 80 is translated by the spacer 30 to the direct the release cap 34 proximally within the rear housing 12, which releases the opener mechanism 60, as described further elsewhere herein. The spacer 30 may be biased distally, e.g., by spring 32, which may, in turn, bias the activation cap 80 distally after completing the injection, also as described further elsewhere herein.
Generally, the outer housing 8 includes a proximal end 8a, e.g., provided on the rear housing 12, an open distal end 8b, e.g., provided on the forward housing 10, and an inner wall extending therebetween to enclose the interior of the device 6. The outer surface between the proximal and distal ends 8a, 8b may be sized and/or shaped to facilitate manipulation of the device 6, e.g., to facilitate placing and pressing the activation cap 80 against a subject's skin to activate the device 6 and inject the agent(s). For example, the outer surface may have a generally cylindrical shape optionally including one or more textures or grip features to facilitate an operator (the subject themselves or a third party) holding the device 6 in one hand and pressing the activation cap 80 against the subject's skin, as described further elsewhere herein. As shown, the proximal end 8a of the housing 8 may include a wall 8c enclosing the proximal end 8a and, optionally, one or more pockets or other features 8d for locking the release cap 34, as described further elsewhere herein.
The outer housing 8 may be formed from multiple, separate components, e.g., clamshell halves, e.g., formed from metal, such as stainless steel, aluminum, and the like, plastic, and/or composite material, by one or more of cold drawing, molding, casting, machining, and the like, that are substantially permanently attached together, e.g., by one or more of welding, soldering, fusing, bonding with adhesive, interference fit, and the like. As shown, the outer housing 8 is formed as separate forward and rear housings 10, 12, which may be assembled separately with respective internal components, and then coupled together, e.g., after loading a syringe 70 into the forward housing 10.
For example, during manufacturing, the forward housing 10 may be assembled with the activation cap 80 and safety cap 86, and a syringe 70 may be loaded into an interior of the forward housing 10, e.g., during manufacturing or during assembly of the device 6 any time before performing an injection. Optionally, as shown in
The rear housing 12 may be assembled with the inner housing 20, the spacer 30, the release cap 34, the gas canister 40, the plunger 50, and the opener mechanism 60 (and any other incidental components), and the rear housing 12 may be coupled to the forward housing 10 at any time. For example, during manufacturing, a syringe 70 may be loaded into the interior of the forward housing 10, and the assembled rear housing 12 may be immediately coupled to the forward housing 10. When the rear housing 12 is attached to the forward housing 10, a distal end 54 of the plunger 50 may be coupled to the piston 74 within the syringe 70, e.g., such that distal movement of the plunger 50 is translated to the piston 74, as described further elsewhere herein.
As shown in
Optionally, the device 6 may include a syringe spacer or adapter 75 that may provide an interface between a distal end 54 of the plunger 50 and the piston 74, e.g., to provide connectors therebetween and/or ensure proper spacing such that the piston 74 is advanced in conjunction with the plunger 50. For example, different length spacers 75 may be provided to allow different length syringes to be loaded into the forward housing 10 while properly positioning the needle 78 adjacent the distal end 8b of the outer housing 8 and allowing the plunger 50 to be properly coupled to the piston 74.
During manufacturing or assembly, a syringe 70 may be selected that may be inserted into the housing 8, e.g., through the opening in the distal end 8b and coupled to the distal end 16 of the drive assembly 12. A syringe spacer 75 may be selected and its distal end 75a may be coupled to the piston 74, e.g., by one or more cooperating threads, as shown, one or more detents or other connectors, and the like. The distal end 54 of the plunger 50 may be inserted into a recess 75b in the syringe spacer 75 when the rear housing 12 is coupled to the forward housing 10. Optionally, the distal end 54 of the plunger 50 and the recess 75b may include cooperating locking features, e.g., one or more threads, detents, and the like (not shown) or the distal end 54 may simply be inserted into the recess 75b to coupled subsequent distal movement of the piston 74 to the plunger 50, as described further elsewhere herein.
Alternatively, the assembled housings 10, 12 may be packaged, stored, and/or otherwise prepared for subsequent assembly. For example, the housing 10, 12 may be shipped or otherwise provided to a manufacturer of the syringe 70, who may load the syringe 70 and couple the housings 10, 12 together to provide the finished device 6. In a further alternative, the assembled housings 10, 12 may be provided to a hospital, physician, or other medical professional, and final assembly may be completed immediately before performing an injection, which may allow a syringe including a specific agent to be loaded before an injection.
The proximal end 10a of the forward housing 10 and the distal end 12b of the rear housing 12 may include one or more cooperating connectors (not shown) to couple the housings 12 together to provide the fully-assembled device 6. For example, the housings 10, 12 may include one or mating threads, detents, and the like, which may permanently couple the housings 12 together. Alternatively, the connectors may allow the housings 10, 12 to be subsequently separated, e.g., after performing an injection, to remove the syringe 70, e.g., to allow the device 6 to be cleaned and reused with a new syringe.
In addition or alternatively, the housings 10, 12 may be permanently attached together by one or more of an interference fit between the ends 10a, 12b, bonding with adhesive, fusing, sonic welding, and the like. In another alternative, the outer housing 8 may be formed as a single, integral component into which the components of the device 6 may be assembled. In these alternatives or even with a two-part housing, the device 6 may be a single use device, which may be disposed of after a single injection.
In the example shown in
The inner housing 20 may be mounted within the outer housing 8 such the inner housing 20 remains substantially stationary within the outer housing 8. Similarly, the gas canister 40 may be mounted within the inner housing 20, e.g., within the first chamber 22, such that the gas canister 40 also remains substantially stationary relative to the outer housing 8. For example, one or more struts, supports, or other structures (not shown) may be provided on the inner and/or outer housings 20, 8 to secure the inner housing 20 and/or the gas canister 40 relative to the outer housing 8.
In the example shown, the proximal cylinder 20a may include an annular wall surrounding the first chamber 22 that includes a uniform diameter first region 22a within which the gas canister 40 is mounted, and second and third regions 22b, 22c within which the opener mechanism 60 is slidably mounted, as described further elsewhere herein. The distal cylinder 20b may have a length such that a distal end 21b of the distal cylinder 20b may abut the syringe when the device 6 is assembled.
Optionally, the distal end 21b may include one or more features that contact the proximal end 72b of the syringe 70, e.g., an O-ring 20d secured on or around the distal end 21b formed from resilient and/or relatively flexible material. The O-ring 20d may prevent the distal end 21b from damaging the syringe 70, e.g., if the barrel 72 is made from glass.
With continued reference to
In one example, the body 42 and cap 44 may be formed from stainless steel or other desired or suitable metal, plastic, or composite material, e.g., formed by one or more of drawing, stamping, machining, casting, molding, and the like. For example, the body 42 may be deep drawn from sheet metal, e.g., a round sheet metal blank of Type 305 stainless steel, using one or more dies and punches (not shown), to form a main barrel region, the enclosed end 42a, an optional tapered shoulder region, and the outlet end 42b defining an opening to which the cap 44 is attached.
As shown, the canister 40 may be oriented with the outlet end 42b proximal to the enclosed end 42a, and the opener mechanism 60 may be provided proximal to the outlet end 44. In the example shown, the cap 44 may be an enclosed cap including a septum or other weakened region (not shown) that may be opened by the opener mechanism. In this example, the opener mechanism may include an opener pin 62 configured to puncture or preferentially tear the septum, as described elsewhere herein. Additional information regarding canisters that may be used and methods for making them may be found in U.S. Publication No. 2017/0258583, the entire disclosure of which is expressly incorporated by reference herein.
Alternatively, the cap 44 may include other closer mechanisms, such as a ball or other member (not shown) that may be biased or otherwise configured to close an outlet in the cap 44 yet may be directed away from the cap 44, e.g., into the canister 40, by the opener mechanism 60 to open the outlet and release the pressurized gas within the cavity 48. In this alternative, the opener pin 62 may include a tapered tip (not shown) sized to enter the outlet and push the closure away from the outlet.
The plunger 50 may be an elongate rod or other member including a proximal end 52 that is slidably disposed within the second chamber 24, e.g., initially immediately adjacent the first chamber 22, and a distal end 54 coupled to the piston 74. The plunger 50 is movable from an initial or retracted position (e.g., shown in
A flange or other guide member 53 may be provided on the proximal end 52 of the plunger 50 that slidably engages a wall of the second chamber 24. Consequently, when pressurized gas enters the second chamber 24 (via the first chamber 22), the pressure generates a distal force to direct the plunger 50 distally from the initial position towards the final position to advance the piston 74 and deliver the one or more agents from the agent chamber 73 through the needle 78 into the subject, as described further elsewhere herein.
Optionally, a wall, orifice, or intermediate passage (not shown) may be provided between the first and second chambers 22, 24. The intermediate passage may have a relatively small diameter to provide a restrictor to reduce pressure rise time within the second chamber 24. For example, the intermediate passage may i) slow down the transient flow of gas, slowing the rise of pressure imparted to the plunger 50, e.g., providing a soft-start to the injection, reducing/eliminating pressure shock waves in the fluid to be injected in the syringe and possibly reducing patient pain as the drug injection is gently initiated; and/or ii) slow down the steady state flow of gas, reducing the otherwise pressure imparted to the plunger 50, providing a limiting effect to the flow rate of the drug injected into the patient.
Optionally, as shown, the plunger 50 may also include a plunger chamber 56, e.g., extending from an open proximal end 52 of the plunger 50 to a closed distal end 54. The plunger chamber 56 may taper inwardly from the proximal end 52 to the distal end 54, as shown, or may have a uniform diameter or other cross-sectional shape along its length. Alternatively, the proximal end 52 of the plunger 50 may include a closed wall and/or the plunger 50 may be a solid rod between the proximal and distal ends 52, 54.
Optionally, the flange 53 on the proximal end 52 of the plunger 50 may include one or more passages (not shown) that extend between proximal and distal surfaces of the flange 53. For example, the flange 53 may include a plurality of circular or other enclosed passages spaced apart from one another around a circumference of the flange 53, each extending between the proximal and distal surfaces.
In this option, the flange 53 may be sized and/or shaped to slidably engage an inner wall of the second chamber 24, e.g., to allow the plunger 50 to move from the initial to the extended position, but may not require O-rings or other seals. Instead, one or more O-rings or other seals may be provided within and/or adjacent the inner housing 10 to seal the first and second chambers 22, 24 and/or otherwise a flow path from the gas canister 40 to the plunger 50. For example, a first O-ring 58a may be provided between the inner housing 10 and the opener mechanism 60, a second O-ring 58b may be provided between a distal end 21b of the inner housing 10 and the plunger 50, and/or a third O-ring 58c may be provided between the proximal and distal cylinders 10a, 10b, if provided as separate components secured together.
In one example, the plunger 50 includes a flange 53 formed as a cylindrical head having a larger outer diameter than the plunger 50, which may be integrally molded or otherwise formed with the plunger 50, or that is manufactured separately and permanently attached to the plunger 50, with one or more passages (not shown) extending between proximal and distal surfaces of the flange 53. When the canister 40 is opened to release the pressurized gas, the initial volume that the gas must fill the first chamber 22 around the canister 40, the second chamber 24 around the plunger 50 and, optionally, the plunger chamber 56, which may result in an initial pressure drop as the gas fills the available volume. However, as the plunger 50 advances, the change in volume that the gas must fill increases only minimally (e.g., the volume the plunger 50 occupies within the second chamber 24 that is displaced out of the distal end 16 of drive assembly 12). Consequently, because the volume change is minimized, the resulting force applied by the pressure on the plunger 50 may remain substantially constant or reduce only slightly. Thus, the resulting force drop applied to the plunger 50 may be minimized, which may provide a more uniform delivery rate of the agent from the syringe 70. Additional information regarding plungers that may provide reduced pressure drop can be found in co-pending U.S. application, Ser. No. 17/965,707, the entire disclosure of which is expressly incorporated by reference herein.
Optionally, the proximal end 52 of the plunger 50 may have a larger diameter or other cross-section than the distal end 54 of the plunger 50. For example, the outer diameter or cross-section may taper between the proximal and distal ends 52, 54 of the plunger 50. Such a tapered shape may increase the cross-sectional area of the plunger 50 as it advances from the initial position towards the final position, which may minimize the change in the distal force applied to the syringe stopper due to volume change, which may be particularly useful for applications where consistent rates of delivery are desired. It will be appreciated that any of these optional features related to the plunger 50 may be combined together or omitted, as desired.
Returning to
For example, the rear housing 12 and the carriage 64 may include cooperating features that prevent the carriage 64 from moving until the device 6 is activated. For example, as best seen in
The release cap 34 and carriage 64 include cooperating features that release the locking features 64a from the rear housing 12 when the device 6 is activated. For example, as shown in
As shown, a central hub 36 is provided on the proximal end 34a of the release cap 34 aligned along the axis 18 distally towards the opener pin 62. The carriage 64 includes a plurality of tabs 65, e.g., arranged concentrically around the axis 18 such that the tabs 65 may slide along the hub 36 as the release cap 34 is directed proximally. Once the hub 36 moves proximally beyond the tabs 65, the tabs 65 are biased to move radially inwardly (towards the central axis 18), thereby directing the locking features 64a inwardly. Once the locking features 64a clear the proximal end 13a of the rear housing 12, e.g., as shown in
During use, the device 6 may be provided initially with the safety cap 86 attached to the distal end 8b of the housing 8, e.g., as shown in
As described elsewhere herein, the safety cap 86 may prevent the activation cap from being directed proximally, e.g., by preventing the activation cap 80 from being contacted. In addition or alternatively, the safety cap 86 may include features that engage the needle shield 79 such that, when the safety cap 86 is removed, the needle shield 79 is also removed. The safety cap 86 and needle shield 79 may prevent the needle 78 from being exposed from the housing 8 prior to use. Once the safety cap 86 and needle shield 79 are removed, the device 6 is ready to be used to perform an injection.
Turning to
For example, as shown in
As the activation cap 80, spacer 30, and release cap 34 move proximally, the inner housing 20 (and canister 40 within the first chamber 22) may remain substantially stationary. As can be seen in
Since the carriage 64 is secured relative to the inner housing 20 by the locking features 64a, the carriage 64 also remains substantially stationary, such that the release cap 34 moves proximally relative to the carriage 64 and the tabs 65 on the carriage 64 slide along the hub 36 on the release cap 34, as best seen in
Due to the spring 66, the carriage 64 is then released and biased to move distally, thereby advancing the opener pin 62 distally to open the outlet of the canister 40, as shown in
When the carriage 64 moves distally, it causes the opener pin 62 to advance and penetrate the septum in the cap 44 (or otherwise open the outlet), thereby releasing the pressurized gas within the canister 40. The released pressurized gas then enters the first chamber 22, e.g., around the canister 40, and passes to the second chamber 24, thereby pressurizing the second chamber 24 to generate a distal force to direct the plunger 50 distally from the initial position towards a final position to deliver the one or more agents from the syringe 70 through the needle 78 into the subject, e.g., as shown in
The operator may monitor the syringe 70 during the injection, e.g., via the window(s) 8c to confirm that the piston 74 has fully advanced distally within the barrel 72 to deliver the entire dose into the subject. Once the injection is completed, the device 6 may be directed away from the subject, thereby withdrawing the needle 78 from the subject's skin. As the device 6 is directed away from the subject's skin, the activation cap 80 is free to move distally and, due to the distal bias of the spring 32, the spacer 30 automatically advances distally, thereby directing the activation cap 80 distally to cover the needle 78 as it is withdrawn.
As best seen in
If the device 6 is a single-use device, the device 6 may then be disposed of. If the device is reusable, e.g., if the forward and rear housings 10, 12 are separable, the rear housing 12 may subsequently be separated from the forward housing 10, and the syringe 70 may be removed. For a reusable device, one or more features may be provided within the device to release any residual pressure within the first and second chambers 22, 24. For example, as shown in
While the invention is susceptible to various modifications, and alternative forms, specific examples thereof have been shown in the drawings and are herein described in detail. It should be understood, however, that the invention is not to be limited to the particular forms or methods disclosed, but to the contrary, the invention is to cover all modifications, equivalents and alternatives falling within the scope of the appended claims.
The present application claims benefit of co-pending U.S. provisional application Ser. No. 63/394,235, filed Aug. 1, 2022, the entire disclosure of which is expressly incorporated by reference herein.
| Number | Date | Country | |
|---|---|---|---|
| 63394235 | Aug 2022 | US |
